Postoperative outcomes of frequent exacerbator patients with Chronic Obstructive Pulmonary Disease after resection of Non-Small Cells Lung Cancer

被引:5
作者
Demiri, Suela [1 ]
Lorut, Christine [2 ]
Rabbat, Antoine [2 ]
van Lang, Daniel Luu [1 ]
Lefebvre, Aurelie [2 ]
Regnard, Jean-Francois [3 ]
Samama, Charles-Marc [1 ]
Dusser, Daniel [2 ]
Roche, Nicolas [2 ]
Alifano, Marco [3 ]
机构
[1] Paris Descartes Univ, Paris Ctr Univ Hosp, Dept Anesthesia, Paris, France
[2] Paris Descartes Univ, Paris Ctr Univ Hosp, Dept Chest Dis, Paris, France
[3] Paris Descartes Univ, Dept Thorac Surg, Paris Ctr Univ Hosp, Paris, France
关键词
Non-small cell lung cancer; surgery; COPD; frequent exacerbator; GOLD; outcome; THORACIC-SURGERY; 30-DAY MORTALITY; COMPLICATIONS; IMPACT; INDEX; COPD; PNEUMONECTOMY; VALIDATION; PREDICTION; GUIDELINES;
D O I
10.1080/15412555.2018.1519784
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Chronic obstructive pulmonary disease (COPD) is a risk factor of post-operative complications after lung cancer resection. The influence of the "frequent exacerbator (FE)" phenotype (at least three exacerbations per year) is unknown. Postoperative outcomes of frequent exacerbators (POFE) was a prospective observational study of patients with COPD undergoing lung resection for cancer. The inclusion criteria were: age >40 years, FEV1/FVC <70%, non-urgent surgery for lung cancer, filled out self-questionnaires. The primary outcome was assessment of postoperative pulmonary complications (purulent tracheobronchitis, atelectasis, pneumonia, acute respiratory failure, need of mechanical ventilation). Secondary outcomes encompassed the prevalence of the FE phenotype and its impact on postoperative complications. A total of 682 patients were screened from June 2014 to October 2015. 93 patients with COPD were included, 21 (23%) were FE. Postoperative tracheobronchitis, atelectasis pneumonia or respiratory failure (isolated or associated) occurred in 47%, 48%, 26%, and 38% of patients, respectively. Non-invasive and invasive mechanical ventilation were necessary in 4 (4%) and 22 (23%) patients. Purulent tracheobronchitis, pneumonia and hypercapnia (this last requiring noninvasive mechanical ventilation) were more frequent in FE (p = 0.043, 0.042, 0.015); however the number of patients wth at least one respiratory complication was not different (76% vs. 52%, p = 0.056). In all patients, multivariate logistic regression identified two independent factors of postoperative respiratory complications: male sex (OR 10.6 [95% CI 1.97-57.6], p = 0.006) and the FE phenotype (OR 6.33 [1.04-38.39], p = 0.045). Occurrence of postoperative complications in patients with COPD is high. FE phenotype is an independent risk factor.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 30 条
[1]   Postoperative pulmonary complications following thoracic surgery: are there any modifiable risk factors? [J].
Agostini, P. ;
Cieslik, H. ;
Rathinam, S. ;
Bishay, E. ;
Kalkat, M. S. ;
Rajesh, P. B. ;
Steyn, R. S. ;
Singh, S. ;
Naidu, B. .
THORAX, 2010, 65 (09) :815-818
[2]   Systemic Inflammation, Nutritional Status and Tumor Immune Microenvironment Determine Outcome of Resected Non-Small Cell Lung Cancer [J].
Alifano, Marco ;
Mansuet-Lupo, Audrey ;
Lococo, Filippo ;
Roche, Nicolas ;
Bobbio, Antonio ;
Canny, Emelyne ;
Schussler, Olivier ;
Dermine, Herve ;
Regnard, Jean-Francois ;
Burroni, Barbara ;
Goc, Jeremy ;
Biton, Jerome ;
Ouakrim, Hanane ;
Cremer, Isabelle ;
Dieu-Nosjean, Marie-Caroline ;
Damotte, Diane .
PLOS ONE, 2014, 9 (09)
[3]   Characterisation of exacerbation risk and exacerbator phenotypes in the POET-COPD trial [J].
Beeh, Kai M. ;
Glaab, Thomas ;
Stowasser, Susanne ;
Schmidt, Hendrik ;
Fabbri, Leonardo M. ;
Rabe, Klaus F. ;
Vogelmeier, Claus F. .
RESPIRATORY RESEARCH, 2013, 14
[4]   Bronchial colonization and postoperative respiratory infections in patients undergoing lung cancer surgery [J].
Belda, J ;
Cavalcanti, M ;
Ferrer, M ;
Serra, M ;
de la Bellacasa, JP ;
Canalis, E ;
Torres, A .
CHEST, 2005, 128 (03) :1571-1579
[5]   Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer [J].
Birim, Ö ;
Maat, APWM ;
Kappetein, AP ;
van Meerbeeck, JP ;
Damhuis, RAM ;
Bogers, AMC .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 23 (01) :30-34
[6]   ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) [J].
Brunelli, A. ;
Charloux, A. ;
Bolliger, C. T. ;
Rocco, G. ;
Sculier, J-P. ;
Varela, G. ;
Licker, M. ;
Ferguson, M. K. ;
Faivre-Finn, C. ;
Huber, R. M. ;
Clini, E. M. ;
Win, T. ;
De Ruysscher, D. ;
Goldman, L. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (01) :17-41
[7]   Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease [J].
Donaldson, GC ;
Seemungal, TAR ;
Bhowmik, A ;
Wedzicha, JA .
THORAX, 2002, 57 (10) :847-852
[8]   The IASLC Lung Cancer Staging Project Proposals for the Revision of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer [J].
Eberhardt, Wilfried E. E. ;
Mitchell, Alan ;
Crowley, John ;
Kondo, Haruhiko ;
Kim, Young Tae ;
Turrisi, Andrew, III ;
Goldstraw, Peter ;
Rami-Porta, Ramon .
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (11) :1515-1522
[9]   The Thoracic Surgery Scoring System (Thoracoscore): Risk model for in-hospital death in 15,183 patients requiring thoracic surgery [J].
Falcoz, Pierre Emmanuel ;
Conti, Massimo ;
Brouchet, Laurent ;
Chocron, Sidney ;
Puyraveau, Marc ;
Mercier, Mariette ;
Etievent, Joseph Philippe ;
Dahan, Marcel .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2007, 133 (02) :325-332
[10]  
Friedlander Adam L, 2007, COPD, V4, P355, DOI 10.1080/15412550701629663